Increase/Decrease in Cash: The total change in cash for the company over the given period.
Promis Neurosciences (PMN) had Increase/Decrease in Cash of $-4.93M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-7.35M |
|
-- |
|
-- |
|
$7.46M |
|
$-7.46M |
|
$0.11M |
|
$-7.35M |
|
$-7.35M |
|
$-7.35M |
|
$-7.35M |
|
$-7.35M |
|
$-7.35M |
|
$-7.46M |
|
$-7.46M |
|
34.85M |
|
34.85M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$13.65M |
|
-- |
|
-- |
|
$13.65M |
|
$4.06M |
|
-- |
|
$0.12M |
|
$4.17M |
|
$9.47M |
|
$9.47M |
|
$9.47M |
|
32.69M |
|
| Cash Flow Statement Financials | |
$-4.93M |
|
-- |
|
-- |
|
$13.29M |
|
$8.36M |
|
|
Increase/Decrease in Cash |
$-4.93M |
$0.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.93M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-77.58% |
|
-77.58% |
|
-53.84% |
|
-77.58% |
|
$0.29 |
|
$-0.14 |
|
$-0.14 |
|